Anchored to UK statute. Last verified 21 June 2026. View source-of-record.

maduediligencechecklist.co.uk

The UK M&A Due Diligence Checklist

Deal structure

Share-purchase due diligence asks


On a share purchase the buyer inherits the target company complete with its history: every historic tax position, contingent liability, in-flight contract and litigation tail. Diligence scope is heavier on Schedules I, III, V and XII than on an asset purchase. The tax deed becomes the single most negotiated annex.

Direct answer

Share-purchase due diligence demands a full historic-liability sweep: corporate authority and PSC reconciliation under CA 2006, six years of corporation-tax computations, an HMRC enquiry trace, every assignable contract's change-of-control clause, litigation register and uninsured-exposure scoping for the tax deed and SPA warranty schedule.


Items emphasised on share deals

Schedule I - Corporate

  • I.2
    Review current articles of association and prior versions adopted within the last six years.[CA 2006 s.18]
    Severity A
  • I.4
    Review statutory registers (members, PSC, directors, secretaries, charges).[CA 2006 s.113]
    Severity A
  • I.5
    Verify PSC register against the Companies House public record and identify any discrepancies.[ECCTA 2023 Part 1]
    Severity A
  • I.6
    Reconcile issued share capital against share-certificate counterfoils and Companies House SH01 filings.[CA 2006 s.554]
    Severity A
  • I.9
    Obtain shareholder agreements, drag/tag arrangements and any side letters.
    Severity A
  • I.14
    Identify any unfiled or overdue Companies House filings; check for proposed strike-off.[Companies House]
    Severity A
  • I.20
    Confirm dividend history was lawful (sufficient distributable reserves at each date).[CA 2006 Part 23]
    Severity A

Schedule III - Tax

  • III.1
    Obtain corporation-tax computations and CT600 returns for the last six years.[CTA 2009]
    Severity A
  • III.2
    Identify any open HMRC enquiries, discovery assessments or pending litigation.
    Severity A
  • III.5
    Review R&D tax-credit claims: methodology, supporting file, advance assurance.[HMRC R&D]
    Severity A
  • III.13
    Review employment-related securities (ERS) returns, EMI option grants and 90-day notifications.
    Severity A
  • III.14
    Confirm EMI option grants meet qualifying-trade and individual-limit conditions.
    Severity A
  • III.15
    Identify any disguised-remuneration or loan-charge exposures.
    Severity A
  • III.21
    Obtain tax-deed draft and reconcile scope to identified exposures.
    Severity A
  • III.22
    Confirm any exit-charge or de-grouping considerations under the proposed deal structure.
    Severity ABuy-side

Schedule V - Legal

  • V.1
    Obtain schedule of all current and threatened litigation; quantify exposures.
    Severity A
  • V.4
    Confirm assignment of IP from founders, contractors and former employees.
    Severity A
  • V.7
    Sample top-20 material contracts for change-of-control, termination and indemnity.
    Severity A
  • V.12
    Identify any director or officer disqualification, censure or fitness-and-propriety issue.
    Severity A
  • V.13
    Confirm regulatory licences and any consent required on change of control.
    Severity A
  • V.16
    Identify any contractual obligation triggered by the transaction (anti-assignment, MAC).
    Severity A

Schedule XII - Insurance

  • XII.4
    Confirm any policy exclusion or aggregate erosion that affects buyer.
    Severity A
  • XII.10
    Identify any uninsured historical exposures requiring SPA indemnity.
    Severity A

Reviewed by Oliver Wakefield-Smith, Founder, Digital SignetLast verified 21 June 2026

This page is anchored to UK primary legislation and named regulator guidance only. Not legal advice. Confirm position with your appointed adviser before signing.